Hotbed/Location

Found 489,381 articles

• Streamline Health® Extends Banking Agreement With Wells Fargo Into 2020

  11/20/2018

  Streamline Health Solutions, Inc. today announced it extended its banking agreement with Wells Fargo into its fiscal year 2020.  The original agreement with Wells Fargo was to expire in November of 2019. 

• Akebia Therapeutics to Participate in Upcoming November and December 2018 Investor Conferences

  11/20/2018

  Akebia Therapeutics, Inc. today announced that it will participate in the following investor conferences

• Bio-Techne To Present At The Citi 2018 Global Healthcare Conference

  11/20/2018

  Bio-Techne Corporation today announced that Dave Eansor, President Protein Sciences will present at the Citi 2018 Global Healthcare Conference on Wednesday, December 5, 2018, at 2:10 p.m. EST.

• Mylan Initiates Voluntary Nationwide Recall of 15 Lots of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine)

  11/20/2018

  Mylan N.V. today announced that its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide recall to the consumer level of select lots of Valsartan-containing products, including six lots of Amlodipine and Valsartan Tablets, USP (including the 5mg/160mg, 10mg/160mg, and 10mg/320mg strengths), seven lots of Valsartan Tablets, USP (including 40 mg, 80 mg, 160 mg, and 320 mg strengths), and two lots of Valsartan and Hydrochlorothiazide Tablets, USP 320mg/25mg strength.

• Xencor to Present at 30th Annual Piper Jaffray Healthcare Conference

  11/20/2018

  Xencor, Inc. today announced that Bassil Dahiyat, Ph.D., president and chief executive officer, will participate in a fireside chat at the 30th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27, 2018 at 10:30 a.m. ET in New York, NY.

• Innovative Test Developed by Navigator Genomics for Medical Cannabis & Prescription Drugs

  11/20/2018

  Navigator Genomics™ (NGT) is the first company to measure and report your personal genetic metabolism and responses for key cannabinoids utilized in Medical Cannabis (MMJ) simultaneously, with 416 of the most popularly prescribed prescription medications (Rx) taken by the most amount of people.

• Exelixis Announces Webcasts of Investor Conference Presentations in November 2018

  11/20/2018

  - Presentations to be webcast on www.exelixis.com -

• Synlogic to Webcast Presentation at the 30th Annual Piper Jaffray Healthcare Conference

  11/20/2018

  Synlogic announced today that Aoife Brennan, M.B., B.Ch., Synlogic’s president and chief executive officer, will provide a corporate update at the 30th Annual Piper Jaffray Healthcare Conference at 8:30 am ET on Wednesday, November 28, 2018, in New York City.

• SS&C Announces Quarterly Dividend Payable on December 17, 2018

  11/20/2018

  SS&C Technologies Holdings, Inc. (Nasdaq: SSNC), a global provider of financial services software and software-enabled services, today announced that consistent with the quarterly dividend policy, its Board of Directors has approved a quarterly dividend of $0.08 per share. 

• Array BioPharma to Present at the 30th Annual Piper Jaffray Healthcare Conference

  11/20/2018

  Array BioPharma Inc. today announced that its Chief Executive Officer, Ron Squarer, will speak at the 30th Annual Piper Jaffray Healthcare Conference in New York. 

• Heron Therapeutics to Present at the 2018 Evercore ISI HealthCONx Conference

  11/20/2018

  Heron Therapeutics, Inc. announced that Barry D. Quart, Pharm.D., Chief Executive Officer of Heron Therapeutics, will participate in a fireside chat at the Evercore ISI HealthCONx Conference on Tuesday, November 27, 2018, at 10:15 a.m. EST at the Boston Harbor Hotel.

• Mylan Statement in Response to FDA Warning Letter Relating to Morgantown Plant

  11/20/2018

  Mylan N.V. today commented on a Warning Letter issued by the U.S. Food and Drug Administration (FDA) on Nov. 9, 2018, relating to its manufacturing facility in Morgantown, West Virginia.

• Kewaunee Scientific Corporation Declares Quarterly Dividend Payable on December 17, 2018

  11/20/2018

  Kewaunee Scientific Corporation announced today its Board of Directors declared a quarterly cash dividend of nineteen cents per outstanding share, payable on December 17, 2018 to stockholders of record at the close of business on December 4, 2018.

• UPDATE - Advisory - Several children's strawberry-flavoured acetaminophen syrups recalled because of defective child-resistant safety caps on the bottles

  11/20/2018

  The recall has been expanded to include all lots of children's strawberry-flavoured acetaminophen syrups labeled as Biomedic, Option+, or Laboratoires Trianon Inc. because of defective child-resistant safety caps.

• Sandata Technologies Achieves HITRUST CSF® Certification and HITRUST Certification of the NIST Cybersecurity Framework to Manage Risk, Improve Security Posture and Meet Compliance Requirements

  11/20/2018

  HITRUST CSF Certification and HITRUST Certification of the NIST Cybersecurity Framework validates Sandata is committed to meeting key regulations and protecting sensitive information.

• FDA Fast Facts: FDA, CDC and partners investigate new E. coli O157:H7 outbreak, urge consumers to avoid romaine lettuce

  11/20/2018

  The U.S. Food and Drug Administration, the Centers for Disease Control and Prevention (CDC), along with state and local partners, are investigating a multistate outbreak of E. coli O157:H7 likely linked to romaine lettuce.

• Huntsman Cancer Institute Breaks Ground for Utah's First Proton Therapy Center

  11/20/2018

  State-of-the-Art Cancer Treatment Center Named in Honor of U.S. Senator Orrin G. Hatch

• Laboratory for Advanced Medicine to Present Data Demonstrating Efficacy of DNA Methylation as Epigenetic Biomarkers for Non-Invasive Breast Cancer Detection at Upcoming San Antonio Breast Cancer Symposium

  11/20/2018

  Presentation showcases ability of blood-based DNA methylation to diagnose disease with high specificity and sensitivity

• FDA warns marketers of products labeled as dietary supplements that contain tianeptine for making unproven claims to treat serious conditions, including opioid use disorder

  11/20/2018

  The U.S. Food and Drug Administration today posted warning letters issued to two companies for the illegal marketing of products labeled as dietary supplements that contain tianeptine, a chemical compound that companies are illegally claiming treats opioid use disorder (OUD), pain and anxiety, and other unlawful and unproven claims.

• Public Health Notice - Outbreak of E. coli infections linked to romaine lettuce

  11/20/2018

  The Public Health Agency of Canada is collaborating with provincial public health partners, the Canadian Food Inspection Agency, Health Canada, as well as the United States Centers for Disease Control and Prevention (U.S. CDC) and the United States Food and Drug Administration (U.S. FDA), to investigate an outbreak of E. coli infections in Ontario and Quebec, and several U.S. states.